IBXXF fundamentals
An in-depth look to Imagion Biosystems Ltd. operating, investing, and financing activities
IBXXF free cash flow for H2 23 is -1.68 M USD. For 2023, IBXXF free cash flow was -5.79 M USD and operating cash flow was -5.66 M USD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
TTM